X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (952) 952
Conference Proceeding (23) 23
Publication (17) 17
Newspaper Article (14) 14
Book / eBook (8) 8
Dissertation (7) 7
Patent (6) 6
Web Resource (5) 5
Book Chapter (3) 3
Magazine Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (317) 317
male (280) 280
female (264) 264
middle aged (205) 205
cardiac & cardiovascular systems (194) 194
aged (160) 160
animals (92) 92
myocardial infarction (86) 86
adult (84) 84
analysis (80) 80
treatment outcome (75) 75
mortality (73) 73
surgery (73) 73
risk factors (67) 67
rats (60) 60
abridged index medicus (57) 57
care and treatment (55) 55
acute coronary syndromes (53) 53
medicine, general & internal (51) 51
therapy (51) 51
research (49) 49
heart failure (48) 48
heart attacks (47) 47
prospective studies (47) 47
time factors (46) 46
cardiovascular (45) 45
double-blind method (45) 45
drug therapy (43) 43
cardiac patients (41) 41
clopidogrel (41) 41
follow-up studies (40) 40
coronary heart disease (39) 39
management (38) 38
heart attack (37) 37
aspirin (36) 36
medicine (36) 36
prognosis (36) 36
risk (36) 36
diabetes (35) 35
patients (35) 35
rats, wistar (35) 35
aged, 80 and over (34) 34
disease (34) 34
health aspects (34) 34
medicine & public health (34) 34
peripheral vascular disease (34) 34
adolescent (33) 33
inflammation (32) 32
myocardial infarction - drug therapy (32) 32
internal medicine (31) 31
myocardial infarction - mortality (31) 31
cardiovascular disease (30) 30
cardiology (29) 29
cardiovascular diseases (29) 29
usage (29) 29
prevention (28) 28
acute coronary syndrome (27) 27
dentistry (27) 27
infectious diseases (27) 27
medical research (27) 27
outcomes (27) 27
ticagrelor (27) 27
lasers (26) 26
patient outcomes (26) 26
pharmacology & pharmacy (26) 26
stroke (26) 26
brazil (25) 25
clinical trials (25) 25
coronary artery disease (25) 25
medicine, experimental (25) 25
platelet aggregation inhibitors - therapeutic use (25) 25
retrospective studies (25) 25
studies (25) 25
acute coronary syndrome - drug therapy (24) 24
coronary vessels (24) 24
engineering, biomedical (24) 24
risk assessment (24) 24
association (23) 23
atherosclerosis (23) 23
diagnosis (23) 23
microbiology (23) 23
myocardial-infarction (23) 23
electrocardiography (22) 22
environmental sciences (22) 22
exercise (21) 21
heart (21) 21
mice (21) 21
myocardial infarction - diagnosis (21) 21
young adult (21) 21
cells (20) 20
child (20) 20
dentistry, oral surgery & medicine (20) 20
diabetes mellitus (20) 20
dosage and administration (20) 20
drug therapy, combination (20) 20
methods (20) 20
parasitology (20) 20
prevalence (20) 20
survival analysis (20) 20
thrombolysis (20) 20
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2012, Volume 367, Issue 14, pp. 1297 - 1309
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 379, Issue 22, pp. 2097 - 2107
Among patients who had had an acute coronary syndrome, the risk of death from coronary heart disease, nonfatal myocardial infarction, stroke, or unstable... 
MEDICINE, GENERAL & INTERNAL | MANAGEMENT | MYOCARDIAL-INFARCTION | TASK-FORCE | EFFICACY | SAFETY | LDL | REDUCING LIPIDS | PCSK9 | MONOCLONAL-ANTIBODY | ASSOCIATION | Double-Blind Method | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - blood | Acute Coronary Syndrome - drug therapy | Acute Coronary Syndrome - complications | Anticholesteremic Agents - therapeutic use | Proprotein Convertase 9 - antagonists & inhibitors | Cardiovascular Diseases - epidemiology | Adult | Cholesterol, LDL - blood | Female | Hypercholesterolemia - complications | Aged | Acute coronary syndrome | Diagnosis | Myocardial infarction | Fees & charges | Lipoproteins (low density) | Heart attacks | Lipids | Cardiovascular disease | Angina | Apolipoprotein B | Ischemia | Heart diseases | Drug dosages | Statins | Cerebral infarction | Stroke | Subtilisin | Angina pectoris | Patients | Low density lipoprotein | Coronary artery disease | Cholesterol | Kexin | Monoclonal antibodies | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Pharmaceuticals | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 389, Issue 10081, pp. 1799 - 1808
Summary Background Dual antiplatelet therapy (DAPT), aspirin plus a P2Y12 inhibitor, is the standard antithrombotic treatment following acute coronary... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | CLOPIDOGREL | MANAGEMENT | MYOCARDIAL-INFARCTION | TICAGRELOR | STENT THROMBOSIS | AMERICAN-COLLEGE | ASSOCIATION TASK-FORCE | INTERVENTION | SECONDARY PREVENTION | ANTIPLATELET THERAPY | Purinergic P2Y Receptor Antagonists - administration & dosage | Ticlopidine - therapeutic use | Humans | Middle Aged | Male | Myocardial Infarction - diagnostic imaging | Rivaroxaban - administration & dosage | Aspirin - administration & dosage | Coronary Angiography - methods | Adenosine - therapeutic use | Thrombolytic Therapy - methods | Ticlopidine - administration & dosage | Female | Myocardial Infarction - physiopathology | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Ticagrelor | Electrocardiography - methods | Purinergic P2Y Receptor Antagonists - therapeutic use | Rivaroxaban - therapeutic use | Double-Blind Method | Treatment Outcome | Adenosine - administration & dosage | Ticlopidine - analogs & derivatives | Acute Coronary Syndrome - drug therapy | Drug Therapy, Combination - methods | Factor Xa Inhibitors - therapeutic use | Myocardial Infarction - drug therapy | Adenosine - analogs & derivatives | Clopidogrel | Aged | Hemorrhage - chemically induced | Medical research | Medical colleges | Aspirin | Mortality | Cardiac patients | Clinical trials | Medicine, Experimental | Dosage and administration | Research institutes | France | Coronary heart disease | Analysis | Myocardial infarction | Therapy | Angiography | Disorders | Angina | Evidence-based medicine | Bleeding | Randomization | Motivation | Atherosclerosis | Safety | Drug therapy | Drug dosages | Heart diseases | Anticoagulants | Research & development--R&D | Strata | Coronary artery | Patients | Thrombosis | Thrombolysis | Inhibitors | Arteriosclerosis | Biomarkers | Infarction | Acute coronary syndromes
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2019, Volume 381, Issue 21, pp. 1995 - 2008
In this randomized, placebo-controlled trial, investigators evaluated the effects of the sodium–glucose cotransporter 2 inhibitor dapagliflozin in patients... 
NEPRILYSIN INHIBITION | OUTCOMES | COTRANSPORTER 2 INHIBITORS | MECHANISM | EMPAGLIFLOZIN | MEDICINE, GENERAL & INTERNAL | Glycated Hemoglobin A - analysis | Humans | Middle Aged | Ventricular Dysfunction, Left - complications | Male | Benzhydryl Compounds - adverse effects | Cardiovascular Diseases - mortality | Female | Glucosides - therapeutic use | Drug Therapy, Combination | Benzhydryl Compounds - therapeutic use | Diabetes Mellitus, Type 2 - complications | Glucosides - adverse effects | Heart Failure - complications | Sodium-Glucose Transporter 2 Inhibitors - therapeutic use | Sodium-Glucose Transporter 2 Inhibitors - adverse effects | Kaplan-Meier Estimate | Stroke Volume - drug effects | Combined Modality Therapy | Hospitalization | Heart Failure - drug therapy | Cardiovascular Agents - therapeutic use | Diabetes Mellitus, Type 2 - blood | Ventricular Dysfunction, Left - drug therapy | Aged | Diabetes Mellitus, Type 2 - drug therapy | Type 2 diabetes | Measurement | Heart failure | Dapagliflozin | Patient outcomes | Physiological aspects | Cardiac output | Drug therapy | Testing | Intravenous administration | Renal function | Clinical trials | Hypoglycemia | Evidence-based medicine | Clinical outcomes | Sodium | Hemoglobin | Patient safety | Diabetes | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Ejection fraction | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 382, Issue 9892, pp. 605 - 613
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2005, Volume 352, Issue 12, pp. 1179 - 1189
Journal Article